ACE Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of ACE Antibodies for advanced research in the field of cardiovascular and renal physiology. ACE Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Angiotensin-converting enzyme (ACE) plays a critical role in the renin-angiotensin system, which regulates blood pressure and fluid balance. By converting angiotensin I to angiotensin II, ACE influences vascular tone and sodium homeostasis, making it a key target in the study of hypertension and heart failure. Understanding ACE's function is essential for developing therapeutic strategies for cardiovascular diseases. ACE research has led to significant breakthroughs in understanding cardiovascular disorders and their treatment options. Ongoing studies continue to reveal new aspects of ACE's role in maintaining cardiovascular health. Current research focuses on exploring novel therapeutic approaches targeting ACE in various cardiovascular conditions. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing our understanding of cardiovascular disease mechanisms and potential treatments.